Energy News / Shareholders Foundation, Inc.

NYSE: CRL Shareholder Notice: Investigation over Potential Wrongdoing at Charles River Laboratories International, Inc.

Via: ReleaseWire

Updated 11:45 AM CDT, Fri, June 08,2018

An investigation on behalf of investors in Charles River Laboratories International, Inc. (NYSE: CRL) shares over potential wrongdoing at Charles River Laboratories International, Inc. was announced and NYSE: CRL stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 06/08/2018 -- An investigation was announced for investors in shares of Charles River Laboratories International, Inc. (NYSE: CRL) concerning possible breaches of fiduciary duties by certain officers and directors at Charles River Laboratories.

Investors who purchased shares of Charles River Laboratories International, Inc. (NYSE: CRL) shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Charles River Laboratories International, Inc. directors breached their fiduciary duties.

Wilmington, MA based Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. Charles River Laboratories International, Inc. reported that its annual Total Revenue rose from over $1.68 billion in 2016 to over $1.85 billion in 2017 and that its Net Income declined from $156.36 million in 2016 to $125.44 million in 2017.

Shares of Charles River Laboratories International, Inc. (NYSE: CRL) rose from $67.20 per share in October 2016 to as high as $119.05 per share in October 2017.

On June 7, 2018, NYSE: CRL shares closed at $112.44 per share.

Those who purchased shares of Charles River Laboratories International, Inc. (NYSE: CRL), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nyse-crl-shareholder-notice-investigation-over-potential-wrongdoing-at-charles-river-laboratories-international-inc-991679.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com